153 related articles for article (PubMed ID: 37867493)
1. Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Ohara M; Suda G; Kohya R; Sasaki T; Yoda T; Yoshida S; Fu Q; Yang Z; Hosoda S; Maehara O; Ohnishi S; Tokuchi Y; Kitagataya T; Kawagishi N; Nakai M; Sho T; Natsuizaka M; Ogawa K; Sakamoto N
Front Nutr; 2023; 10():1272728. PubMed ID: 37867493
[TBL] [Abstract][Full Text] [Related]
2. Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis.
Ebadi M; Dunichand-Hoedl AR; Rider E; Kneteman NM; Shapiro J; Bigam D; Dajani K; Mazurak VC; Baracos VE; Montano-Loza AJ
JHEP Rep; 2022 Jul; 4(7):100495. PubMed ID: 35600667
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer.
Cheng E; Caan BJ; Chen WY; Irwin ML; Prado CM; Cespedes Feliciano EM
Clin Nutr; 2022 Dec; 41(12):2607-2613. PubMed ID: 36306565
[TBL] [Abstract][Full Text] [Related]
4. Abdominal adipose tissue radiodensity is associated with survival after colorectal cancer.
Feliciano EMC; Winkels RM; Meyerhardt JA; Prado CM; Afman LA; Caan BJ
Am J Clin Nutr; 2021 Dec; 114(6):1917-1924. PubMed ID: 34510172
[TBL] [Abstract][Full Text] [Related]
5. Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy.
Ebadi M; Moctezuma-Velazquez C; Meza-Junco J; Baracos VE; DunichandHoedl AR; Ghosh S; Sarlieve P; Owen RJ; Kneteman N; Montano-Loza AJ
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033166
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue radiodensity: A new prognostic biomarker in people with multiple myeloma.
da Cunha AD; Silveira MN; Takahashi MES; de Souza EM; Mosci C; Ramos CD; Brambilla SR; Pericole FV; Prado CM; Mendes MCS; Carvalheira JBC
Nutrition; 2021 Jun; 86():111141. PubMed ID: 33596528
[TBL] [Abstract][Full Text] [Related]
7. Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
Sakamaki A; Yokoyama K; Koyama K; Morita S; Abe H; Kamimura K; Takamura M; Terai S
PLoS One; 2020; 15(11):e0242582. PubMed ID: 33201936
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue indices predict prognosis in hodgkin lymphoma.
Özbalcı D; Erdoğan M; Alanoğlu EG; Şengül SS; Yüceer K; Eroğlu HN; Yağcı S
Leuk Res; 2024 Mar; 138():107457. PubMed ID: 38382169
[TBL] [Abstract][Full Text] [Related]
9. Muscle and fat composition in patients with newly diagnosed multiple myeloma.
Abdallah NH; Nagayama H; Takahashi N; Gonsalves W; Fonder A; Dispenzieri A; Dingli D; Buadi FK; Lacy MQ; Hobbs M; Gertz MA; Binder M; Kapoor P; Warsame R; Hayman SR; Kourelis T; Hwa YL; Lin Y; Kyle RA; Rajkumar SV; Broski SM; Kumar SK
Blood Cancer J; 2023 Dec; 13(1):185. PubMed ID: 38086801
[TBL] [Abstract][Full Text] [Related]
10. A novel body composition risk score (B-Score) and overall survival among patients with nonmetastatic breast cancer.
Cheng E; Caan BJ; Chen WY; Prado CM; Cespedes Feliciano EM
Clin Nutr; 2024 Apr; 43(4):981-987. PubMed ID: 38471402
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment.
Tamai Y; Iwasa M; Eguchi A; Shigefuku R; Sugimoto R; Tanaka H; Kobayashi Y; Mizuno S; Nakagawa H
Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1269-1276. PubMed ID: 36317773
[TBL] [Abstract][Full Text] [Related]
12. Change in abdominal, but not femoral subcutaneous fat CT-radiodensity is associated with improved metabolic profile after bariatric surgery.
Dadson P; Rebelos E; Honka H; Juárez-Orozco LE; Kalliokoski KK; Iozzo P; Teuho J; Salminen P; Pihlajamäki J; Hannukainen JC; Nuutila P
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2363-2371. PubMed ID: 32919861
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
Cancer Manag Res; 2018; 10():2231-2239. PubMed ID: 30100754
[TBL] [Abstract][Full Text] [Related]
14. Abdominal adiposity as a prognosis biomarker of clinical outcome in metastatic colorectal cancer.
Oikawa KH; Juliani FL; Carrilho LAO; Pozzuto L; Padilha DMH; Silveira MN; Costa FO; Macedo LT; da Cunha Júnior AD; Mendes MCS; Carvalheira JBC
Nutrition; 2023 Mar; 107():111913. PubMed ID: 36563436
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis.
Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Hasegawa K; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):915-925. PubMed ID: 28627027
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma.
Fujita M; Takahashi A; Hayashi M; Okai K; Abe K; Ohira H
Hepatol Res; 2019 Jul; 49(7):778-786. PubMed ID: 30884044
[TBL] [Abstract][Full Text] [Related]
18. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
19. Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.
Sugama Y; Miyanishi K; Osuga T; Tanaka S; Hamaguchi K; Ito R; Sakamoto H; Kubo T; Ohnuma H; Murase K; Takada K; Kobune M; Kato J
JGH Open; 2021 Dec; 5(12):1335-1343. PubMed ID: 34950776
[TBL] [Abstract][Full Text] [Related]
20. High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting.
Antoun S; Bayar A; Ileana E; Laplanche A; Fizazi K; di Palma M; Escudier B; Albiges L; Massard C; Loriot Y
Eur J Cancer; 2015 Nov; 51(17):2570-7. PubMed ID: 26278649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
